| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.05 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.077 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |